About Anastrozole Tablets IP
Explore the valuable therapeutic benefits of New Anastrozole Tablets IP, a paragon of quality designed for hormone therapy. Each film-coated tablet contains 1 mg of the renowned active ingredient, Anastrozole, and is formulated for easy oral administration. This prescription-only medication is a non-steroidal aromatase inhibitor, indicated for the treatment of breast cancer in postmenopausal women. Carefully packaged in convenient 1 x 10 blister packs, it is marketed by a reputed Indian exporter. This last chance product offers an odorless, white to off-white round tablet with rigorous quality standards, ensuring a shelf life of 36 months.
Type Of Usage and Applications of Anastrozole Tablets IP
Anastrozole Tablets IP are widely used in pharmaceutical environments for hormone therapy, particularly in the treatment of breast cancer among postmenopausal women. Beyond its specific use in oncology, the formulation's aromatase inhibition properties make it valuable in the management of estrogen-dependent conditions. Its general use remains within prescription guidelines, ensuring the best therapeutic outcomes. The easy-to-swallow, film-coated tablets support patient adherence, making them suitable for both hospital and outpatient care settings.
Packaging Details, Sample Policy, and Certifications
Our Anastrozole Tablets IP arrive in secure blister packs, with stock ready for immediate dispatch and global express shipping options. Each batch is clearly marked with batch numbers, and an estimate for timely supply can be provided upon request. Samples may be available based on distributor policies and region. These tablets meet stringent international certification standards, attesting to their quality and reliability for pharmaceutical clients worldwide.
FAQ's of Anastrozole Tablets IP:
Q: How should Anastrozole Tablets IP be stored for optimal efficacy?
A: It is important to store Anastrozole Tablets IP below 30C, away from light and moisture, to maintain their effectiveness throughout the 36-month shelf life.
Q: What is the main indication for Anastrozole Tablets IP?
A: Anastrozole Tablets IP are primarily indicated for the treatment of breast cancer in postmenopausal women as part of hormone therapy.
Q: Where are these Anastrozole Tablets IP manufactured and exported from?
A: These tablets are manufactured and exported from India by a renowned, reputed Indian pharmaceutical exporter.
Q: What should I consider regarding the usage of Anastrozole Tablets IP?
A: Anastrozole Tablets IP should only be used under medical prescription, following your healthcare provider's instructions for dosage and administration.
Q: What makes these Anastrozole Tablets IP a paragon of quality?
A: They are produced with premium film coating for easy swallowing, strict adherence to international certifications, and utilize high-quality Anastrozole for consistent therapeutic effect.